Page 5 - மெர்க் ஆராய்ச்சி ஆய்வகங்கள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

23 Aug 2021 Recombinant proteins require strict quality control, as quality issues affect the reliability of the intended downstream application. Cell and gene therapy research in particular demands a higher quality of protein that adheres to strict quality control and has comprehensive validation. In this exclusive SelectScience ® webinar, Dr. Deborah Moore-Lai, Director of Protein Development at Abcam, will introduce a new range of premium bioactive proteins. During the session, Moore-Lai will be detailing Abcam’s manufacturing workflow, as well as outlining the company’s mission to support scientists in achieving their goals in cell and gene therapy research and other research areas.

Deborah moore laiCell signaling technologyMerck research laboratoriesProtein developmentProtein development at abcamProteins initiativeAntibody productionCell signalingசெல் சமிக்ஞை தொழில்நுட்பம்மெர்க் ஆராய்ச்சி ஆய்வகங்கள்ப்ரோடீந் வளர்ச்சிஆன்டிபாடி ப்ரொடக்ஶந்செல் சமிக்ஞை